|By PR Newswire||
|February 20, 2013 04:32 PM EST||
Regulators Reject Expensive 'Protected Class' Approach in the Exchanges
WASHINGTON, Feb. 20, 2013 /PRNewswire-USNewswire/ -- The Pharmaceutical Care Management Association (PCMA) released the following statement today on the Department of Health and Human Services (HHS) Essential Health Benefits (EHB) final rule:
"Regulators rejected the 'protected class' approach that shields competing drug companies from offering competitive pricing to be included on formularies.
"Unfortunately, 'protected classes' are used in Medicare and increase costs by $4.2 billion, according to the Centers for Medicare and Medicaid Services (CMS). There is no evidence that 'protected classes' improve quality or access and they should not be imposed on plans in the Exchanges.
"Plans can negotiate greater price concessions from competing drug makers – and reduce overall prescription drug benefit costs – when they have more flexibility to design clinically-based formularies."
PCMA represents the nation's pharmacy benefit managers (PBMs), which improve affordability and quality of care through the use of electronic prescribing (e-prescribing), generic alternatives, mail-service pharmacies, and other innovative tools for 210-plus million Americans.
SOURCE Pharmaceutical Care Management Association
- "All It Took Was One E-Mail to Larry," Says Former eBay Research Director As He Moves to Google
- Google Ramps Up Its Mobile Reach: Launches "Mobile Web Search"
- VoIP Update: Yahoo! Buys DialPad
- Ericsson + Napster = World's First "Wireless Digital Music" Brand
- Free Guest Passes for the SOA World Conference & Expo in NYC
- SYS-CON i-Technology Podcast August 30, 2005
- A Flair for Food - Health-Conscious Cooking Is This Chef's Cup Of Tea
- Sony PSP May Feature Porn
- Kapow Helps Seiko UK, Provides SMS Text-Alert Services
- South Korea is World's Largest Phisher
- Will the Mac OS Now Be Offered by Dell?
- UK Targeted for Trojan Attacks